Detect, Quantify, and Correct Clinical Trial Bias

The first end-to-end platform for clinical trial bias management. From demographic underrepresentation to methodological flaws, detect issues early and correct them before regulatory submission.

Bias Threatens Trial Validity

From demographic underrepresentation to methodological flaws, bias compromises scientific validity, distorts treatment effects, and triggers regulatory rejection. Most issues remain invisible until submission—when it's too late.

80%+

of clinical trials contain systematic bias

$17M-$200M

cost per protocol modification

30%

potential cost reduction with bias correction

Types of Bias We Detect

1

Demographic Bias

Underrepresentation of women, elderly, children, and ethnic minorities in trial populations

2

Selection Bias

Flawed randomization or allocation concealment affecting group assignment

3

Performance Bias

Inadequate blinding causing behavioral differences between groups

4

Detection Bias

Outcome measurement influenced by knowledge of treatment assignment

5

Attrition Bias

Non-random patient withdrawals skewing study results

6

Reporting Bias

Selective reporting of statistically significant outcomes only

Business and Clinical Impact

Financial Risk

Protocol modifications due to bias cost $17.3M (Phase I) to $200M (Phase III). Studies with high risk of bias show exaggerated treatment effects that fail to replicate, wasting development investment.

Regulatory Scrutiny

FDA and EMA increasingly require documented evidence of representative enrollment and robust methodology. Trials with inadequate randomization, poor blinding, or unrepresentative populations face rejection.

The First End-to-End Bias Management Platform

Clinequal integrates detection, quantification, explanation, and correction into a single workflow. Unlike EDC systems or generic data cleaning tools, we address systematic bias at its source with regulatory-ready outputs.

Bias Scanner

Automated detection of demographic imbalances and methodological flaws: population underrepresentation, randomization issues, blinding gaps, attrition patterns, and selective reporting.

Quantification & Explainability

Fairness metrics quantify bias magnitude and statistical significance. Explainable AI (XAI) traces root causes to specific enrollment sites, inclusion criteria, or protocol design decisions.

Correction & Simulation

Evidence-based correction strategies: statistical weighting, subsampling, targeted enrollment recommendations. What-if simulations model outcome changes before protocol amendments.

Regulatory Compliance

Audit-ready reports for EMA and FDA submission, aligned with Cochrane standards. Full audit trails, GDPR/MDR compliance, ISO 27001 security. Documentation in 24+ languages.

Interactive Demo

See It in Action

Explore bias detection on sample clinical trial datasets. No signup required.

clinequal.com/demo
Try the Demo

2 sample trials • ~2 min walkthrough

From Dataset Upload to Regulatory Submission

Six integrated modules transform biased trial data into defensible, representative datasets with full documentation for submission.

01

Detect Bias

Automated scanning for demographic imbalances (gender, age, ethnicity) and methodological issues: randomization flaws, blinding gaps, attrition patterns, and reporting inconsistencies.

02

Quantify Impact

Fairness metrics measure the magnitude and statistical significance of each bias type. Visualizations show how bias may inflate or deflate treatment effect estimates.

03

Explain Root Causes

Explainable AI traces bias to specific protocol decisions: allocation methods, blinding procedures, outcome definitions, dropout patterns, or selective reporting practices.

04

Correct Datasets

Evidence-based correction strategies: statistical weighting, sensitivity analyses, imputation methods for missing data, and recommendations for protocol amendments.

05

Simulate Scenarios

What-if modeling: 'How do results change if we adjust for attrition bias?' or 'What if allocation concealment was improved?' Test corrections before implementation.

06

Generate Reports

Regulatory-ready documentation for EMA/FDA submission, aligned with Cochrane methodology. Full audit trails, 24+ languages, GDPR and MDR compliance built in.

Recognition & Achievements

Selected from 495 applicants for Fit4Start Luxembourg. Winner of the US-Italy Hackathon and Startcup Campania Social Impact Prize.

July 2025

That's a Hackathon! Winner

US-Italy Hackathon for Innovative Business Ideas

Naples

View post
October 2025

Social Impact Prize

Startcup Campania

5th Place Overall

View post
December 2025

National Pitch

Premio Nazionale Innovazione

Ferrara

View post
2025

Fit4Start Finalist

Luxembourg Accelerator Program

Luxembourg

Academic Collaborations

Politecnico di MilanoUniversità di Napoli Federico IILuxembourg Institute of Science and TechnologyLinköping UniversityUniversity of LuxembourgKTH Royal Institute of TechnologyKarolinska Institute

Leadership Team

Expertise spanning AI/ML, bioinformatics, healthcare data science, software engineering, and regulatory compliance. Advised by scientists in the top 2% most cited globally.

Andrea de Giorgio

Andrea de Giorgio

CEO

PhD Industrial Engineering (KTH), 10+ years AI/ML, serial entrepreneur

Felicia Burtscher

Felicia Burtscher

CPO

MSc Bioinformatics (Imperial), MBA, 10+ years healthcare data science

Pasquale Junior Montò

Pasquale Junior Montò

CTO

Software engineer, Apple Developer Academy alumnus, AI module lead

Enrico De Cupertinis

Enrico De Cupertinis

CCO

Doctor in Design for Community, branding & digital marketing expert

Eleonora Di Napoli

Eleonora Di Napoli

CFO

Master's Economics, Management & Sustainability, ESG specialist

Reduce Regulatory Risk with Representative Datasets

Schedule a consultation to see how Clinequal addresses bias in your trial data before submission.

Email us at info@clinequal.com

Follow on LinkedIn